血清生物标志物可提前5年识别炎症性肠病高风险患者
该研究基于美国国防部医学监测系统1998至2013年的血清样本,纳入克罗恩病200例、溃疡性结肠炎199例及健康对照200例,检测抗菌抗体和1129种蛋白质,采用功能主成分分析构建多变量预测模型。结果显示51种蛋白质标志物组合预测5年内克罗恩病诊断的AUROC为0.76,1年内为0.87;而预测溃疡性结肠炎的AUROC仅为0.56(5年)和0.72(1年)。
要点
- 51种血清蛋白质标志物组合可预测5年内克罗恩病诊断,AUROC为0.76,1年内达0.87。
- 克罗恩病发病前血清蛋白质变化涉及补体级联、溶酶体、先天免疫应答和糖胺聚糖代谢。
- 血清抗体和蛋白质对溃疡性结肠炎的预测效能较低,5年内AUROC仅0.56,1年内0.72。
核心结论
- 血清抗体和蛋白质组合可高精度预测5年内将诊断克罗恩病的患者,但未发现与未来溃疡性结肠炎诊断相关的生物标志物。
研究设计与样本
- 研究获取美国国防部医学监测系统1998至2013年存档的血清样本,包括克罗恩病200例、溃疡性结肠炎199例和健康对照200例。
- 检测样本中抗微生物抗体(抗酿酒酵母菌IgA或IgG、抗大肠杆菌外膜孔蛋白C、抗CBir1、抗鞭毛蛋白2、抗鞭毛蛋白X和核周抗中性粒细胞胞质抗体)及1129种蛋白质。
- 采用功能主成分分析得出每个标志物随时间变化的轨迹,并用于多变量模型预测疾病状态,通过AUROC评估不同诊断前时间点的预测性能。
主要发现
- 51种蛋白质标志物组合预测5年内克罗恩病诊断的AUROC为0.76,预测1年内诊断的AUROC为0.87。
- 基于组合中的蛋白质,克罗恩病即将发病与补体级联、溶酶体、先天免疫应答和糖胺聚糖代谢的变化相关。
- 血清抗体和蛋白质预测5年内溃疡性结肠炎诊断的AUROC仅为0.56,预测1年内诊断的AUROC为0.72。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Biomarkers are needed to identify patients at risk for development of inflammatory bowel diseases. We aimed to identify serum biomarkers of Crohn's disease and ulcerative colitis that can be detected and quantified before diagnosis. METHODS: We obtained serum samples from patients archived before a diagnosis of Crohn's disease (n = 200) or ulcerative colitis (n = 199), as well as from 200 healthy individuals (controls), collected from 1998 through 2013 as part of the US Defense Medical Surveillance System. We measured levels of antibodies against microbes (anti-Saccharomyces cerevisiae IgA or IgG, anti-Escherichiacoli outer membrane porin C, anti-CBir1, anti-flagellin 2, anti-flagellin X, and perinuclear anti-neutrophil cytoplasmic antibodies) and 1129 proteins in each sample. We then used functional principal component analysis to derive the time-varying trajectory for each marker, which then was used in a multivariate model to predict disease status. Predictive performances at different prediagnosis timepoints were evaluated using area under the receiver operating characteristic curves (AUROCs). Biological pathways that were up-regulated in serum from patients with Crohn's disease were identified based on changes in protein abundance at different time periods preceding diagnosis. RESULTS: We identified a panel of 51 protein biomarkers that were predictive of Crohn's disease within 5 years with an AUROC of 0.76 and a diagnosis within 1 year with an AUROC of 0.87. Based on the proteins included in the panel, imminent development of CD was associated with changes in the complement cascade, lysosomes, innate immune response, and glycosaminoglycan metabolism. Serum antibodies and proteins identified patients who received a diagnosis of ulcerative colitis within 5 years with an AUROC of only 0.56 and within 1 year with an AUROC of 0.72. CONCLUSIONS: We identified a panel of serum antibodies and proteins that were predictive of patients who will receive a diagnosis of Crohn's disease within 5 years with high accuracy. By contrast we did not identify biomarkers associated with future diagnosis of ulcerative colitis.
引用
- Torres J, Petralia F, Sato T, et al. Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before Diagnosis. Gastroenterology. 2020. PMID: 32165208. doi:10.1053/j.gastro.2020.03.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。